DMAQR

Deep Medicine Acquisition Corp. Rights
DMAQR

Overview Fund Activity
Delisted

DMAQR was delisted on the 31st of January, 2024.

Back to rankings

26 hedge funds and large institutions have $2.4M invested in Deep Medicine Acquisition Corp. Rights in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Holders
26
Holders Change
-3
Holders Change %
-10.34%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CAC
1
Cowen and Company
New York
$234K
2
Parallax Volatility Advisers
2
Parallax Volatility Advisers
California
$43.4K
3
KPF
3
K2 Principal Fund
Ontario, Canada
$97.8K
4
FLC
4
Fifth Lane Capital
Texas
$30K
5
HF
5
HRT Financial
New York
$14K

Top Sellers

1
MP
1
Mangrove Partners
Connecticut
$0
2
YCM
2
Yakira Capital Management
Connecticut
$223K
3
SCM
3
Shaolin Capital Management
Florida
$157K
4
Walleye Capital
4
Walleye Capital
New York
$110K
5
RCM
5
Radcliffe Capital Management
Pennsylvania
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
$11.5K – – –
MP
27
Mangrove Partners
Connecticut
– -$238K -1,485,437 Closed
RCM
28
Radcliffe Capital Management
Pennsylvania
– -$11.9K -70,000 Closed
AA
29
Ancora Advisors
Ohio
– -$722 -5,155 Closed
UBS Group
30
UBS Group
Switzerland
– -$56 -400 Closed
1
2